Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case

Galactorrhea, as an adverse effect of psychotropic medications, usually develops due to high dose of antipsychotics. Selective serotonin reuptake inhibitors (SSRIs) have also been reported to be related to galactorrhea. To the best of our knowledge, no previous study reported galactorrhea with methy...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekinci, Ozalp, Gunes, Serkan, Ekinci, Nuran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565079/
https://www.ncbi.nlm.nih.gov/pubmed/28783939
http://dx.doi.org/10.9758/cpn.2017.15.3.282
_version_ 1783258359989796864
author Ekinci, Ozalp
Gunes, Serkan
Ekinci, Nuran
author_facet Ekinci, Ozalp
Gunes, Serkan
Ekinci, Nuran
author_sort Ekinci, Ozalp
collection PubMed
description Galactorrhea, as an adverse effect of psychotropic medications, usually develops due to high dose of antipsychotics. Selective serotonin reuptake inhibitors (SSRIs) have also been reported to be related to galactorrhea. To the best of our knowledge, no previous study reported galactorrhea with methylphenidate (MPH) use. Hereby, we report a case of an adolescent girl who developed galactorrhea after increasing his modifed-release oral MPH to 50 mg/day while under treatment of sertraline and very low dose haloperidol.
format Online
Article
Text
id pubmed-5565079
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Korean College of Neuropsychopharmacology
record_format MEDLINE/PubMed
spelling pubmed-55650792017-08-23 Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case Ekinci, Ozalp Gunes, Serkan Ekinci, Nuran Clin Psychopharmacol Neurosci Case Report Galactorrhea, as an adverse effect of psychotropic medications, usually develops due to high dose of antipsychotics. Selective serotonin reuptake inhibitors (SSRIs) have also been reported to be related to galactorrhea. To the best of our knowledge, no previous study reported galactorrhea with methylphenidate (MPH) use. Hereby, we report a case of an adolescent girl who developed galactorrhea after increasing his modifed-release oral MPH to 50 mg/day while under treatment of sertraline and very low dose haloperidol. Korean College of Neuropsychopharmacology 2017-08 2017-08-31 /pmc/articles/PMC5565079/ /pubmed/28783939 http://dx.doi.org/10.9758/cpn.2017.15.3.282 Text en Copyright © 2017, Korean College of Neuropsychopharmacology This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ekinci, Ozalp
Gunes, Serkan
Ekinci, Nuran
Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case
title Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case
title_full Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case
title_fullStr Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case
title_full_unstemmed Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case
title_short Galactorrhea Probably Related with Switching from Osmotic-release Oral System Methylphenidate (MPH) to Modified-release MPH: An Adolescent Case
title_sort galactorrhea probably related with switching from osmotic-release oral system methylphenidate (mph) to modified-release mph: an adolescent case
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565079/
https://www.ncbi.nlm.nih.gov/pubmed/28783939
http://dx.doi.org/10.9758/cpn.2017.15.3.282
work_keys_str_mv AT ekinciozalp galactorrheaprobablyrelatedwithswitchingfromosmoticreleaseoralsystemmethylphenidatemphtomodifiedreleasemphanadolescentcase
AT gunesserkan galactorrheaprobablyrelatedwithswitchingfromosmoticreleaseoralsystemmethylphenidatemphtomodifiedreleasemphanadolescentcase
AT ekincinuran galactorrheaprobablyrelatedwithswitchingfromosmoticreleaseoralsystemmethylphenidatemphtomodifiedreleasemphanadolescentcase

Ejemplares similares